|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,578.00 GBX | +0.85% |
|
+0.18% | -1.54% |
| 11:03am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 11:03am | Race to launch weight-loss pill heats up as Novo wins UK approval | RE |
| Market Cap | 280B 243B 224B 210B 392B 26,787B 400B 2,669B 1,034B 12,912B 1,050B 1,028B 44,896B | P/E Ratio 2026 * |
22.7x | P/E Ratio 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 299B 260B 239B 224B 419B 28,663B 428B 2,856B 1,106B 13,817B 1,124B 1,100B 48,040B | EV / Sales 2026 * |
4.73x | EV / Sales 2027 * | 4.35x |
| Free-Float |
96.63% | Yield 2026 * |
1.85% | Yield 2027 * | 1.95% |
Last Transcript: AstraZeneca PLC
| 1 day | +0.70% | ||
| 1 week | +0.18% | ||
| Current month | -1.62% | ||
| 1 month | +0.56% | ||
| 3 months | -6.26% | ||
| 6 months | -0.13% | ||
| Current year | -1.54% |
| 1 week | 11,364 |  | 13,878 |
| 1 month | 11,232 | | 14,120 |
| Current year | 11,232 | | 15,732 |
| 1 year | 10,103 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,680 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 19 | Sell | See Remarks | -11,893 | 0.0008% | ||
| May. 13 | Fiscal year | Chief Executive Officer | 18,359 | 0.0012% | ||
| May. 05 | Free | See Remarks | 1 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +1.53% | +2.63% | +42.82% | +159.33% | 1,013B | |
| +0.47% | +5.12% | +54.48% | +50.00% | 574B | |
| +0.27% | +0.34% | +17.86% | +63.88% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +3.83% | +1.51% | +20.22% | +61.40% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +3.38% | -2.76% | +14.92% | +61.33% | 151B | |
| +2.09% | +1.89% | +6.92% | -34.40% | 146B | |
| Average | +1.37% | +2.48% | +18.30% | +37.77% | 353.45B | |
| Weighted average by Cap. | +1.14% | +3.87% | +28.45% | +67.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.32B 54.95B 50.65B 47.46B 88.68B 6,063B 90.53B 604B 234B 2,923B 238B 233B 10,162B | 67.16B 58.28B 53.72B 50.34B 94.05B 6,430B 96.01B 641B 248B 3,100B 252B 247B 10,777B |
| Net income | 12.43B 10.79B 9.94B 9.32B 17.41B 1,190B 17.77B 119B 45.92B 574B 46.66B 45.65B 1,995B | 14.09B 12.22B 11.27B 10.56B 19.73B 1,349B 20.14B 134B 52.04B 650B 52.88B 51.74B 2,260B |
| Net Debt | 19.6B 17.01B 15.68B 14.69B 27.44B 1,876B 28.01B 187B 72.4B 904B 73.56B 71.98B 3,145B | 12.67B 10.99B 10.13B 9.49B 17.74B 1,213B 18.11B 121B 46.8B 585B 47.55B 46.53B 2,033B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 13,578.00 p | +0.85% | 1,142,221 |
| 26-06-10 | 13,464.00 p | -1.23% | 1,762,153 |
| 26-06-09 | 13,632.00 p | -1.19% | 1,908,834 |
| 26-06-08 | 13,796.00 p | -0.45% | 1,741,438 |
| 26-06-05 | 13,858.00 p | +2.24% | 1,729,795 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
